author_facet Ozer, Hatice Gulcin
Usubalieva, Aisulu
Dorrance, Adrienne
Yilmaz, Ayse Selen
Caligiuri, Michael
Marcucci, Guido
Huang, Kun
Ozer, Hatice Gulcin
Usubalieva, Aisulu
Dorrance, Adrienne
Yilmaz, Ayse Selen
Caligiuri, Michael
Marcucci, Guido
Huang, Kun
author Ozer, Hatice Gulcin
Usubalieva, Aisulu
Dorrance, Adrienne
Yilmaz, Ayse Selen
Caligiuri, Michael
Marcucci, Guido
Huang, Kun
spellingShingle Ozer, Hatice Gulcin
Usubalieva, Aisulu
Dorrance, Adrienne
Yilmaz, Ayse Selen
Caligiuri, Michael
Marcucci, Guido
Huang, Kun
Cancer Informatics
Identification of Medium-Sized Copy Number Alterations in Whole-Genome Sequencing
Cancer Research
Oncology
author_sort ozer, hatice gulcin
spelling Ozer, Hatice Gulcin Usubalieva, Aisulu Dorrance, Adrienne Yilmaz, Ayse Selen Caligiuri, Michael Marcucci, Guido Huang, Kun 1176-9351 1176-9351 SAGE Publications Cancer Research Oncology http://dx.doi.org/10.4137/cin.s14023 <jats:p> The genome-wide discoveries such as detection of copy number alterations (CNA) from high-throughput whole-genome sequencing data enabled new developments in personalized medicine. The CNAs have been reported to be associated with various diseases and cancers including acute myeloid leukemia. However, there are multiple challenges to the use of current CNA detection tools that lead to high false-positive rates and thus impede widespread use of such tools in cancer research. In this paper, we discuss these issues and propose possible solutions. First, since the entire genome cannot be mapped due to some regions lacking sequence uniqueness, current methods cannot be appropriately adjusted to handle these regions in the analyses. Thus, detection of medium-sized CNAs is also being directly affected by these mappability problems. The requirement for matching control samples is also an important limitation because acquiring matching controls might not be possible or might not be cost efficient. Here we present an approach that addresses these issues and detects medium-sized CNAs in cancer genomes by (1) masking unmappable regions during the initial CNA detection phase, (2) using pool of a few normal samples as control, and (3) employing median filtering to adjust CNA ratios to its surrounding coverage and eliminate false positives. </jats:p> Identification of Medium-Sized Copy Number Alterations in Whole-Genome Sequencing Cancer Informatics
doi_str_mv 10.4137/cin.s14023
facet_avail Online
Free
finc_class_facet Medizin
format ElectronicArticle
fullrecord blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuNDEzNy9jaW4uczE0MDIz
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuNDEzNy9jaW4uczE0MDIz
institution DE-D275
DE-Bn3
DE-Brt1
DE-Zwi2
DE-D161
DE-Gla1
DE-Zi4
DE-15
DE-Pl11
DE-Rs1
DE-105
DE-14
DE-Ch1
DE-L229
imprint SAGE Publications, 2014
imprint_str_mv SAGE Publications, 2014
issn 1176-9351
issn_str_mv 1176-9351
language English
mega_collection SAGE Publications (CrossRef)
match_str ozer2014identificationofmediumsizedcopynumberalterationsinwholegenomesequencing
publishDateSort 2014
publisher SAGE Publications
recordtype ai
record_format ai
series Cancer Informatics
source_id 49
title Identification of Medium-Sized Copy Number Alterations in Whole-Genome Sequencing
title_unstemmed Identification of Medium-Sized Copy Number Alterations in Whole-Genome Sequencing
title_full Identification of Medium-Sized Copy Number Alterations in Whole-Genome Sequencing
title_fullStr Identification of Medium-Sized Copy Number Alterations in Whole-Genome Sequencing
title_full_unstemmed Identification of Medium-Sized Copy Number Alterations in Whole-Genome Sequencing
title_short Identification of Medium-Sized Copy Number Alterations in Whole-Genome Sequencing
title_sort identification of medium-sized copy number alterations in whole-genome sequencing
topic Cancer Research
Oncology
url http://dx.doi.org/10.4137/cin.s14023
publishDate 2014
physical CIN.S14023
description <jats:p> The genome-wide discoveries such as detection of copy number alterations (CNA) from high-throughput whole-genome sequencing data enabled new developments in personalized medicine. The CNAs have been reported to be associated with various diseases and cancers including acute myeloid leukemia. However, there are multiple challenges to the use of current CNA detection tools that lead to high false-positive rates and thus impede widespread use of such tools in cancer research. In this paper, we discuss these issues and propose possible solutions. First, since the entire genome cannot be mapped due to some regions lacking sequence uniqueness, current methods cannot be appropriately adjusted to handle these regions in the analyses. Thus, detection of medium-sized CNAs is also being directly affected by these mappability problems. The requirement for matching control samples is also an important limitation because acquiring matching controls might not be possible or might not be cost efficient. Here we present an approach that addresses these issues and detects medium-sized CNAs in cancer genomes by (1) masking unmappable regions during the initial CNA detection phase, (2) using pool of a few normal samples as control, and (3) employing median filtering to adjust CNA ratios to its surrounding coverage and eliminate false positives. </jats:p>
container_start_page 0
container_title Cancer Informatics
container_volume 13s3
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
_version_ 1792325760859504654
geogr_code not assigned
last_indexed 2024-03-01T12:10:42.547Z
geogr_code_person not assigned
openURL url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Identification+of+Medium-Sized+Copy+Number+Alterations+in+Whole-Genome+Sequencing&rft.date=2014-01-01&genre=article&issn=1176-9351&volume=13s3&pages=CIN.S14023&jtitle=Cancer+Informatics&atitle=Identification+of+Medium-Sized+Copy+Number+Alterations+in+Whole-Genome+Sequencing&aulast=Huang&aufirst=Kun&rft_id=info%3Adoi%2F10.4137%2Fcin.s14023&rft.language%5B0%5D=eng
SOLR
_version_ 1792325760859504654
author Ozer, Hatice Gulcin, Usubalieva, Aisulu, Dorrance, Adrienne, Yilmaz, Ayse Selen, Caligiuri, Michael, Marcucci, Guido, Huang, Kun
author_facet Ozer, Hatice Gulcin, Usubalieva, Aisulu, Dorrance, Adrienne, Yilmaz, Ayse Selen, Caligiuri, Michael, Marcucci, Guido, Huang, Kun, Ozer, Hatice Gulcin, Usubalieva, Aisulu, Dorrance, Adrienne, Yilmaz, Ayse Selen, Caligiuri, Michael, Marcucci, Guido, Huang, Kun
author_sort ozer, hatice gulcin
container_start_page 0
container_title Cancer Informatics
container_volume 13s3
description <jats:p> The genome-wide discoveries such as detection of copy number alterations (CNA) from high-throughput whole-genome sequencing data enabled new developments in personalized medicine. The CNAs have been reported to be associated with various diseases and cancers including acute myeloid leukemia. However, there are multiple challenges to the use of current CNA detection tools that lead to high false-positive rates and thus impede widespread use of such tools in cancer research. In this paper, we discuss these issues and propose possible solutions. First, since the entire genome cannot be mapped due to some regions lacking sequence uniqueness, current methods cannot be appropriately adjusted to handle these regions in the analyses. Thus, detection of medium-sized CNAs is also being directly affected by these mappability problems. The requirement for matching control samples is also an important limitation because acquiring matching controls might not be possible or might not be cost efficient. Here we present an approach that addresses these issues and detects medium-sized CNAs in cancer genomes by (1) masking unmappable regions during the initial CNA detection phase, (2) using pool of a few normal samples as control, and (3) employing median filtering to adjust CNA ratios to its surrounding coverage and eliminate false positives. </jats:p>
doi_str_mv 10.4137/cin.s14023
facet_avail Online, Free
finc_class_facet Medizin
format ElectronicArticle
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
geogr_code not assigned
geogr_code_person not assigned
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuNDEzNy9jaW4uczE0MDIz
imprint SAGE Publications, 2014
imprint_str_mv SAGE Publications, 2014
institution DE-D275, DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161, DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1, DE-L229
issn 1176-9351
issn_str_mv 1176-9351
language English
last_indexed 2024-03-01T12:10:42.547Z
match_str ozer2014identificationofmediumsizedcopynumberalterationsinwholegenomesequencing
mega_collection SAGE Publications (CrossRef)
physical CIN.S14023
publishDate 2014
publishDateSort 2014
publisher SAGE Publications
record_format ai
recordtype ai
series Cancer Informatics
source_id 49
spelling Ozer, Hatice Gulcin Usubalieva, Aisulu Dorrance, Adrienne Yilmaz, Ayse Selen Caligiuri, Michael Marcucci, Guido Huang, Kun 1176-9351 1176-9351 SAGE Publications Cancer Research Oncology http://dx.doi.org/10.4137/cin.s14023 <jats:p> The genome-wide discoveries such as detection of copy number alterations (CNA) from high-throughput whole-genome sequencing data enabled new developments in personalized medicine. The CNAs have been reported to be associated with various diseases and cancers including acute myeloid leukemia. However, there are multiple challenges to the use of current CNA detection tools that lead to high false-positive rates and thus impede widespread use of such tools in cancer research. In this paper, we discuss these issues and propose possible solutions. First, since the entire genome cannot be mapped due to some regions lacking sequence uniqueness, current methods cannot be appropriately adjusted to handle these regions in the analyses. Thus, detection of medium-sized CNAs is also being directly affected by these mappability problems. The requirement for matching control samples is also an important limitation because acquiring matching controls might not be possible or might not be cost efficient. Here we present an approach that addresses these issues and detects medium-sized CNAs in cancer genomes by (1) masking unmappable regions during the initial CNA detection phase, (2) using pool of a few normal samples as control, and (3) employing median filtering to adjust CNA ratios to its surrounding coverage and eliminate false positives. </jats:p> Identification of Medium-Sized Copy Number Alterations in Whole-Genome Sequencing Cancer Informatics
spellingShingle Ozer, Hatice Gulcin, Usubalieva, Aisulu, Dorrance, Adrienne, Yilmaz, Ayse Selen, Caligiuri, Michael, Marcucci, Guido, Huang, Kun, Cancer Informatics, Identification of Medium-Sized Copy Number Alterations in Whole-Genome Sequencing, Cancer Research, Oncology
title Identification of Medium-Sized Copy Number Alterations in Whole-Genome Sequencing
title_full Identification of Medium-Sized Copy Number Alterations in Whole-Genome Sequencing
title_fullStr Identification of Medium-Sized Copy Number Alterations in Whole-Genome Sequencing
title_full_unstemmed Identification of Medium-Sized Copy Number Alterations in Whole-Genome Sequencing
title_short Identification of Medium-Sized Copy Number Alterations in Whole-Genome Sequencing
title_sort identification of medium-sized copy number alterations in whole-genome sequencing
title_unstemmed Identification of Medium-Sized Copy Number Alterations in Whole-Genome Sequencing
topic Cancer Research, Oncology
url http://dx.doi.org/10.4137/cin.s14023